Literature DB >> 1295372

Decreased histamine content and metabolism in mammary cancer tissue from C3H mice.

D Kierska1, H Szymańska, C Maslinski.   

Abstract

Histamine (HA) level and its metabolism in adenocarcinoma mammae, spontaneously growing cancer in C3H mice, were examined in relation to the type of tumor, intensity of tumor vascularization and the presence or absence of a secretory function. Histamine concentration being in mammary gland one of the highest among mammalian organs (418 nmol/g) was decreased by 90% in tumor (34 nmol/g). Similarly, histidine decarboxylase (HDC) activity dropped from approximately 7.6 pmol/min/g in normal gland to an undetectable level in adenocarcinoma mammae. Of the two main HA degrading enzymes, namely, diamine oxidase and histamine N-methyl-transferase (HMT), only HMT could be detected in mammary gland, either healthy or neoplastic, and its activity was about 5-fold lower in tumor than in the control tissue (1 nmol/g/min vs. 5.2 nmol/g/min). The pattern of changes in histaminergic parameters evoked by the tumor was similar irrespective of the morphological type it represented, characteristics of its vascular bed or whether or not it showed secretory activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295372     DOI: 10.1007/bf02028113

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  15 in total

1.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE.

Authors:  R J WURTMAN; J AXELROD
Journal:  Biochem Pharmacol       Date:  1963-12       Impact factor: 5.858

2.  The central nervous system, neurohypophysis and milk ejection.

Authors:  G W HARRIS
Journal:  Proc R Soc Lond B Biol Sci       Date:  1958-12-17

3.  Some observations on the contractile tissue of the mammary glands.

Authors:  J L LINZELL
Journal:  J Physiol       Date:  1955-11-28       Impact factor: 5.182

4.  Skin allografts generate an enhanced production of histamine and histamine-producing cell-stimulating factor (HCSF) by spleen cells in response to T cell mitogens.

Authors:  M Dy; B Lebel
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

5.  Increase in histidine decarboxylase activity in mouse skin after application of the tumor promoter tetradecanoylphorbol acetate.

Authors:  T Watanabe; Y Taguchi; K Sasaki; K Tsuyama; Y Kitamura
Journal:  Biochem Biophys Res Commun       Date:  1981-05-15       Impact factor: 3.575

Review 6.  Histamine and microcirculation.

Authors:  R W Schayer
Journal:  Life Sci       Date:  1974-08-01       Impact factor: 5.037

7.  Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.

Authors:  J Bartholeyns; M Bouclier
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

8.  Histamine and its catabolism in tumour-bearing rat and mouse.

Authors:  C Maśliński; D Kierska; K Sasiak; B Adamas
Journal:  Agents Actions       Date:  1984-04

9.  Histamine in C3H/W mice carrying spontaneous tumors of the mammary gland.

Authors:  C Maslinski; D Kierska
Journal:  Agents Actions       Date:  1991-05

10.  A sum of 14C-putrescine metabolites as a measure of DAO activity. Column chromatography assay.

Authors:  W A Fogel; M Ulatowska; K Adach; Z Osińska
Journal:  Agents Actions       Date:  1985-04
View more
  1 in total

1.  A cultured approach to canine urothelial carcinoma: molecular characterization of five cell lines.

Authors:  S G Shapiro; D W Knapp; Matthew Breen
Journal:  Canine Genet Epidemiol       Date:  2015-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.